We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
626
The Mosaic Company
MOS
$7.09B
$782K 0.01%
27,877
-80,674
-74% -$2.19M
CX icon
627
Cemex
CX
$17.4B
$777K 0.01%
118,405
+98,825
+505% +$625K
VER
628
DELISTED
VEREIT, Inc.
VER
$772K 0.01%
20,749
THS
629
DELISTED
Treehouse Foods
THS
$761K 0.01%
+14,500
New +$657K
XEC
630
DELISTED
CIMAREX ENERGY CO
XEC
$756K 0.01%
7,427
+2,076
+39% +$197K
CHL
631
DELISTED
China Mobile Limited
CHL
$756K 0.01%
17,030
+700
+4% +$32.2K
CAE icon
632
CAE Inc. Common Shares
CAE
$8.1B
$747K 0.01%
35,988
+17,042
+90% +$337K
WCG
633
DELISTED
Wellcare Health Plans, Inc.
WCG
$739K 0.01%
3,000
PAGP icon
634
Plains GP Holdings
PAGP
$5.23B
$717K 0.01%
30,000
+13,118
+78% +$321K
CMG icon
635
Chipotle Mexican Grill
CMG
$40.8B
$708K 0.01%
82,100
-720,050
-90% -$5.89M
PRSP
636
DELISTED
Perspecta Inc. Common Stock
PRSP
$696K 0.01%
+33,850
New +$758K
CDK
637
DELISTED
CDK Global, Inc.
CDK
$691K 0.01%
10,621
CTRA
638
DELISTED
Coterra Energy
CTRA
$687K 0.01%
28,866
-5,254
-15% -$123K
MOH icon
639
Molina Healthcare
MOH
$10.3B
$686K 0.01%
7,000
ENR icon
640
Energizer
ENR
$1.44B
$682K 0.01%
10,832
+1,832
+20% +$108K
NCLH icon
641
Norwegian Cruise Line
NCLH
$8.89B
$679K 0.01%
14,369
+340
+2% +$17.9K
THC icon
642
Tenet Healthcare
THC
$20.1B
$671K 0.01%
+20,000
New +$622K
HE icon
643
Hawaiian Electric Industries
HE
$2.33B
$670K 0.01%
19,544
CAJ
644
DELISTED
Canon, Inc.
CAJ
$670K 0.01%
20,494
+94
+0.5% +$3.25K
WHR icon
645
Whirlpool
WHR
$2.42B
$667K 0.01%
4,563
-76,017
-94% -$11.6M
HII icon
646
Huntington Ingalls Industries
HII
$11.3B
$660K 0.01%
3,045
-18,250
-86% -$4.24M
TCOM icon
647
Trip.com Group
TCOM
$27.5B
$631K 0.01%
13,245
-10,000
-43% -$452K
DRI icon
648
Darden Restaurants
DRI
$22.5B
$620K 0.01%
+5,795
New +$531K
RDHL
649
Redhill Biopharma
RDHL
$3.85M
$608K 0.01%
71
HACK icon
650
Amplify Cybersecurity ETF
HACK
$2.63B
$603K 0.01%
16,300
+4,000
+33% +$148K

Similar funds

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.